Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China · Delayed Price · Currency is CNY 63.39
-0.41 (-0.64%)
Jul 30, 2025, 2:45 PM CST
Jiangsu Hengrui Medicine Revenue
Jiangsu Hengrui Medicine had revenue of 7.21B CNY in the quarter ending March 31, 2025, with 20.14% growth. This brings the company's revenue in the last twelve months to 29.19B, up 25.16% year-over-year. In the year 2024, Jiangsu Hengrui Medicine had annual revenue of 27.98B with 22.63% growth.
Revenue (ttm)
29.19B
Revenue Growth
+25.16%
P/S Ratio
14.53
Revenue / Employee
1.44M
Employees
20,238
Market Cap
424.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.98B | 5.16B | 22.63% |
| Dec 31, 2023 | 22.82B | 1.54B | 7.26% |
| Dec 31, 2022 | 21.28B | -4.63B | -17.87% |
| Dec 31, 2021 | 25.91B | -1.83B | -6.59% |
| Dec 31, 2020 | 27.73B | 4.45B | 19.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |
| Beijing Wantai Biological Pharmacy Enterprise | 1.89B |